ResMed (RMD)
(Delayed Data from NYSE)
$216.59 USD
+2.40 (1.12%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $216.63 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 61 - 80 ( 532 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
MedTech: Not Sleeping on OSA; Conference Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
PHG Updates Appear Modestly Positive for RMD, but Likely Not Too Surprising
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Medical Technology: Leaning In on Improving Fundamentals
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 31123
Provider: Stock Traders Daily
Analyst: Research Department